InvestorsHub Logo
Followers 13
Posts 1547
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Thursday, 03/18/2021 5:17:58 PM

Thursday, March 18, 2021 5:17:58 PM

Post# of 34626
FINALLY

March 18, 2021
5:10 pm ET
*Marker Therapeutics shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and announced a $6 price target.

4:43 pm ET
*Marker Therapeutics Director John Wilson Reported Purchase of 1,714,285 Shares @ Avg Price of $1.75/Share in Form 4 Filing

4:42 pm ET
*Marker Therapeutics CEO Peter Hoang Reported Purchase of 142,857 @ Avg Price of $1.75/Share in Form 4 Filing

4:21 pm ET
Marker Therapeutics Initiated at Overweight by Cantor Fitzgerald
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News